Syringe adapter with a driver for agitation of the syringe content
    2.
    发明申请
    Syringe adapter with a driver for agitation of the syringe content 有权
    注射器适配器带有用于搅动注射器内容物的驱动器

    公开(公告)号:US20050234337A1

    公开(公告)日:2005-10-20

    申请号:US10523744

    申请日:2003-08-07

    申请人: Martin Browne

    发明人: Martin Browne

    摘要: Administration by injection or infusion to patients of an injectable liquid for diagnostic or therapeutic purposes is provided by a syringe adapter connectable with an automatic syringe pump and a syringe containing contents to be dispensed. The syringe adapter includes an adapter body receivable by the syringe pump, a syringe retainer for retaining the syringe, and a syringe driver for agitating the contents of the syringe. More particularly the invention relates to an adapter connectable with a syringe pump and methods for delivery of an injectable liquid using such adapter. By connecting an adapter according to the invention to a syringe and a syringe pump, rotation of the syringe is achieved and homogeneity of the injectable is preserved. Particularly, the injectable liquid is an ultrasound contrast agent comprising an aqueous dispersion of gas-filled microbubbles or of particulate matter.

    摘要翻译: 通过注射或输注用于诊断或治疗目的的可注射液体的给药是通过可与自动注射泵连接的注射器适配器和含有待分配内容物的注射器来提供的。 注射器适配器包括可由注射器泵可接受的适配器主体,用于保持注射器的注射器保持器和用于搅动注射器内容物的注射器驱动器。 更具体地,本发明涉及可与注射器泵连接的适配器以及使用这种适配器递送可注射液体的方法。 通过将根据本发明的适配器连接到注射器和注射器泵,实现注射器的旋转并保持注射器的均匀性。 特别地,可注射液体是包含充气微泡或颗粒物质的水性分散体的超声造影剂。

    Para-hydrogen labeled agents and their use in magnetic resonance imaging
    4.
    发明申请
    Para-hydrogen labeled agents and their use in magnetic resonance imaging 审中-公开
    对位氢标记的药物及其在磁共振成像中的应用

    公开(公告)号:US20040024307A1

    公开(公告)日:2004-02-05

    申请号:US10395002

    申请日:2003-03-24

    IPC分类号: A61B005/05

    摘要: The invention provides a method of magnetic resonance investigation of a sample, said method comprising: (i) reacting para-hydrogen enriched hydrogen with a hydrogenatable MR imaging agent precursor containing a non-hydrogen non-zero nuclear spin nucleus to produce a hydrogenated MR imaging agent; (ii) administering said hydrogenated MR imaging agent to said sample; (iii) exposing said sample to radiation of a frequency selected to excite nuclear spin transitions of said non-zero nuclear spin nucleus in said hydrogenated MR imaging agent; (v) detecting magnetic resonance signals of said non-zero nuclear spin nucleus from said sample; and (vi) optionally, generating an image or biological functional data or dynamic flow data from said detected signals.

    摘要翻译: 本发明提供了一种对样品进行磁共振研究的方法,所述方法包括:(i)将富氢氢与含有非氢非零核自旋核的可氢化MR成像剂前体反应以产生氢化MR成像 代理人 (ii)将所述氢化MR成像剂施用于所述样品; (iii)将所述样品暴露于所选择的频率的辐射以激发所述氢化MR成像剂中所述非零核自旋核的核自旋跃迁; (v)从所述样品检测所述非零核自旋核的磁共振信号; 和(vi)可选地,从所述检测到的信号生成图像或生物功能数据或动态流量数据。

    Contrast agents
    5.
    发明申请
    Contrast agents 失效
    对比剂

    公开(公告)号:US20030228254A1

    公开(公告)日:2003-12-11

    申请号:US10370092

    申请日:2003-02-21

    摘要: The invention provides a composition of matter of the formula (I): V-L-R where V is an organic group having binding affinity for an angiotensin II receptor site, L is a linker moiety or a bond, and R is a moiety detectable in in vivo imaging of a human or animal body, with the provisos that where V is angiotensin or a peptidic angiotensin derivative or analog then V-L-R is other than a non-metal radionuclide substituted peptide (e.g. 125I substituted angiotensin II) and L-V is other than simply a peptide with a chelating agent amide bonded to a side chain thereof. This composition of matter may be used to image cardiovascular diseases and disorders.

    摘要翻译: 本发明提供了式(I)的物质组合物:VLR,其中V是对血管紧张素II受体位点具有结合亲和力的有机基团,L是连接体部分或键,R是在体内成像中可检测的部分 的条件是V是血管紧张素或肽血管紧张素衍生物或类似物,然后VLR不是非金属放射性核素取代肽(例如125 I取代的血管紧张素II),而LV不仅仅是简单的 具有与其侧链键合的螯合剂酰胺的肽。 这种物质的组成可用于影像心血管疾病和病症。

    Method of magnetic resonance imaging
    6.
    发明授权
    Method of magnetic resonance imaging 失效
    磁共振成像方法

    公开(公告)号:US06901281B2

    公开(公告)日:2005-05-31

    申请号:US09815140

    申请日:2001-03-22

    IPC分类号: G01R33/28 A61B5/05

    CPC分类号: G01R33/5601

    摘要: The invention provides a method of magnetic resonance imaging of regional blood oxygenation which comprises administering into the vasculature of a vascularized human or non-human animal subject a T2 blood pool contrast agent, detecting a magnetic resonance signal from at least part of the vasculature of said subject into which said contrast agent distributes, and manipulating said signal to generate an indication of the partial pressure of oxygen (pO2) in at least part of said vasculature.

    摘要翻译: 本发明提供了一种区域性血氧合磁共振成像方法,该方法包括向血管化的人或非人类动物施用T 2细胞血液造影剂的血管,检测来自 所述受试者的脉管系统的至少一部分,所述造影剂分布在所述血管系统中,并且操纵所述信号以产生至少部分所述脉管系统中氧的分压指示(p0> 2N)。

    Contrast agents
    7.
    发明申请
    Contrast agents 失效
    对比剂

    公开(公告)号:US20040009122A1

    公开(公告)日:2004-01-15

    申请号:US10462836

    申请日:2003-06-17

    摘要: The invention provides a composition of matter of the formula (I): V-L-R, where V is a vector moiety having affinity for an angiogenesis-related endothelias cell receptor, L is a linker moiety or a bond and R is a detectable moiety, characterised in that V is a non-peptidic organic group, or V is peptidic and R is a macromolecular or particulate species providing a multiplicity of labels detectable in in vivo imaging.

    摘要翻译: 本发明提供式(I)的物质组合物:VLR,其中V是对血管生成相关内皮细胞受体具有亲和性的载体部分,L是连接体部分或键,R是可检测部分,其特征在于 V是非肽类有机基团,或V是肽类,R是提供在体内成像中可检测到的多种标记物的大分子或微粒物质。

    Optical Imaging Contrast Agents For Imaging Lung Cancer
    8.
    发明申请
    Optical Imaging Contrast Agents For Imaging Lung Cancer 审中-公开
    用于成像肺癌的光学成像对比剂

    公开(公告)号:US20070212305A1

    公开(公告)日:2007-09-13

    申请号:US10582893

    申请日:2004-12-17

    IPC分类号: A61K49/04

    摘要: The invention provides contrast agents for optical imaging of lung cancer in patients. The contrast agents may be used in diagnosis of lung cancer, for follow up of progress in disease development, for follow up of treatment of lung cancer and for surgical guidance. Further, the invention provides methods for optical imaging of lung cancer in patients.

    摘要翻译: 本发明提供了用于患者肺癌光学成像的造影剂。 造影剂可用于诊断肺癌,用于跟踪疾病发展进展,随访肺癌治疗和手术指导。 此外,本发明提供了患者中肺癌的光学成像方法。

    Use of amines
    9.
    发明授权
    Use of amines 失效
    胺的使用

    公开(公告)号:US07060731B2

    公开(公告)日:2006-06-13

    申请号:US10242082

    申请日:2002-09-12

    CPC分类号: C07C215/06 C07C217/04

    摘要: This application relates to the use of certain amines of formula (I) for combatting and preventing systemic and local complement activation, and in particular to the use of meglumine and derivatives and optionally salts thereof in combatting and preventing said activation. The amines are also of use in combatting activation of the kinin/kallikrein system or blood coagulation system.

    摘要翻译: 本申请涉及某些式(I)胺用于对抗和预防全身和局部补体活化,特别是使用葡甲胺及其衍生物和任选的盐来防治和预防所述活化。 胺也可用于拮抗激肽/激肽释放酶系统或凝血系统的激活。

    Preparation of tri-iodo benzene compounds
    10.
    再颁专利
    Preparation of tri-iodo benzene compounds 有权
    三碘苯化合物的制备

    公开(公告)号:USRE38856E1

    公开(公告)日:2005-10-25

    申请号:US10279502

    申请日:2002-10-24

    CPC分类号: C07C231/12 C07C237/46

    摘要: The invention provides a process by which ultra low salt content triiodinated aromatic compounds may be isolated from a highly acidic hot triiodination raction reaction medium in a straightforward fashion. The process involves increasing the pH to above 5 a value in the range of 3 to 7 with sodium hydroxide, addition of sodium bisulphite and/or sodium dithionite, addition of seed crystals, cooling slowly, and washing the collected precipitate with water.

    摘要翻译: 本发明提供了一种可以从高度酸性的热三碘化物中分离出超低盐含量的三碘化芳族化合物的方法。<βdelete-start id =“DEL-S-00001”date =“20051025”?> raction <?delete-end id =“DEL-S-00001”?> <?insert-start id =“INS-S-00001”date =“20051025”?> reaction <?insert-end id =“INS-S-00001”?> 以直截了当的方式。 该过程包括将pH增加到<?delete-start id =“DEL-S-00002”date =“20051025”?> 5以上<?delete-end id =“DEL-S-00002”?> <? start id =“INS-S-00002”date =“20051025”?> 3〜7的范围内的值??????????? 和/或连二亚硫酸钠,加入晶种,缓慢冷却,并用水洗涤收集的沉淀。